Stroke trials in China

In China 489 Also abroad 2128

352 of 489 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in China
Transcranial Direct Current Stimulation for Neurogenic Overactive Bladder Symptoms Among People With Stroke
Where
Hong Kong
Age
18 years to 80 years
People
60
Run by
The Hong Kong Polytechnic University
See details and how to joinNCT07768137
No phaseNot yet taking people in China
EEG Feedback-Based Vagus Nerve Stimulation for Post-Stroke Dysphagia
Where
Beijing, Fuzhou, Xi'an, Xi’an, Zhangzhou, Zhengzhou
Age
18 years to 80 years
People
60
Run by
First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT07894315
No phaseNot yet taking people in China
Prehospital Response and Emergency Stroke Transport Optimisation
Where
Beijing
Age
18 years and over
People
320
Run by
Xuanwu Hospital, Beijing
See details and how to joinNCT07892053
Phase 3Taking people
Tenecteplase or Reteplase as Bridging Thrombolysis Before Thrombectomy in Acute Ischemic Cerebrovascular Events
Where
Beijing, Rizhao, Wuhan, Xiangtan, Ya'an
Age
18 years and over
People
1,440
Run by
Yongjun Wang
See details and how to joinNCT07748039
Phase 4Not yet taking people in China
Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke
Where
Hangzhou
Age
18 years and over
People
852
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07609654
No phaseNot yet taking people in China
Early Administration of Angong Niuhuang Pill for Disabling Acute Ischemic Stroke (EAGER Trial)
Where
Beijing
Age
18 years to 80 years
People
1,200
Run by
Xuanwu Hospital, Beijing
See details and how to joinNCT07882030
Phase 2Not yet taking people in China
A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke
Where
Beijing
Age
18 years to 80 years
People
300
Run by
Shanghai Pharmaceuticals Holding Co., Ltd
See details and how to joinNCT07754825
Phase 2Taking people
Advancing Reperfusion Therapy for Ischemic Stroke: Safety and Efficacy of Anakinra for Futile Reperfusion Following Endovascular Treatment in Patients With Acute Ischemic Stroke
Where
Beijing, Linyi, Luoyang, Panlong, Puyang, Weifang
Age
18 years to 80 years
People
159
Run by
Beijing Tiantan Hospital
See details and how to joinNCT07423975
No phaseEnrolling by invitation
Fufang Tongluo Decoction as an Adjunct to Aspirin and Atorvastatin for Ischemic Moyamoya Disease
Where
Nanjing
Age
18 years to 60 years
People
128
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07875335
No phaseNot yet taking people in China
Early Anticoagulation Therapy After Endovascular Treatment for Acute Ischemic Stroke With Atrial Fibrillation
Where
Shanghai, Suzhou
Age
18 years and over
People
474
Run by
The Fourth Affiliated Hospital of Soochow University
See details and how to joinNCT07849777
No phaseTaking people
Adenosine A2a Receptor-Mediated Neuroinflammation in Remote Ischemic Conditioning for Post-Stroke Sleep Disorders
Where
Chengdu
Age
18 years to 80 years
People
136
Run by
Sichuan Academy of Medical Sciences
See details and how to joinNCT07874594
No phaseTaking people
Endovascular Therapy for Acute Basilar Artery Occlusion With Large Ischemic Core
Where
Hefei
Age
18 years to 85 years
People
256
Run by
The First Affiliated Hospital of University of Science and Technology of China
See details and how to joinNCT07672795
Phase 2Taking people
Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2)
Where
Anyang, Beijing, Huzhou, Jiuquan, Lishui, Shangqiu, Suzhou, Taizhou, Xuzhou, Yueqing, Yulin, Zhangzhou, Zibo
Age
18 years to 80 years
People
204
Run by
Capital Medical University
See details and how to joinNCT07800572
No phaseNot yet taking people in China
INtensive liPid-lowering Therapy for Acute High-risk IntracRanial or Extracranial atheroSclerosis -II (INSPIRES-2)
Where
Beijing
Age
35 years to 80 years
People
242
Run by
Beijing Tiantan Hospital
See details and how to joinNCT07341958
No phaseTaking people
SUPERSTAR: Aspiration vs. Stent Retriever in Anterior Circulation LVO
Where
Shanghai
Age
18 years and over
People
708
Run by
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
See details and how to joinNCT07555977
Phase 3Taking people
Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke
Where
Hefei
Age
18 years and over
People
616
Run by
The First Affiliated Hospital of Anhui Medical University
See details and how to joinNCT07776873
No phaseTaking people
Transcranial Focused Ultrasound Neuromodulation for Post-Stroke Motor Dysfunction
Where
Taizhou
Age
18 years to 75 years
People
60
Run by
Jiangsu Taizhou People's Hospital
See details and how to joinNCT07637825
No phaseNot yet taking people in China
Dentate-Targeted Temporal Interference Stimulation for Post-Stroke Dysphagia
Where
Hangzhou
Age
18 years to 80 years
People
112
Run by
Zhejiang University
See details and how to joinNCT07766668
Phase 2/3Not yet taking people in China
Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial
Where
Suzhou
Age
19 years to 80 years
People
726
Run by
yifang zhu
See details and how to joinNCT07734792
Phase 3Taking people
Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging
Where
Baise City, Chongzuo, Guangzhou, Guigang, Laibin, Liuzhou, Nanning, Qinzhou, Xiamen, Yulin
Age
18 years and over
People
352
Run by
First Affiliated Hospital of Guangxi Medical University
See details and how to joinNCT07475949
No phaseTaking people
Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS
Where
Wuhu
Age
18 years and over
People
264
Run by
First Affiliated Hospital of Wannan Medical College
See details and how to joinNCT06143488
No phaseNot yet taking people in China
CEST-PROTECT: Proximal Flow Control With a Balloon Guide Catheter Plus Distal Embolic Protection: a Randomised, Open-label Trial Evaluating Cerebral Protection Techniques
Where
Beijing
Age
18 years to 80 years
People
500
Run by
Xuanwu Hospital, Beijing
See details and how to joinNCT07841132
Phase 2Not yet taking people in China
ALT001 in Patients With Ischemic Stroke in the Sequelae Stage
Where
Beijing
Age
18 years to 80 years
People
200
Run by
Darwin Origin (Hubei) Biopharmaceutical Co., Ltd.
See details and how to joinNCT07841496
Phase 3Taking people
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
Where
Anshan, Anyang, Baoji, Beijing, Bengbu, Bozhou, Cangzhou, Changde, Changsha, Chengdu, Chenzhou, Dalian, Dandong, Datong, Dezhou, Dongying, Fushun, Fuxin, Fuzhou, Guangzhou, Guankou, Guigang, Haerbin, Haidian, Haikou, Hainan, Handan, Hebi, Heyuan, Huaibei, Jiamusi, Jiangzuo, Jiaxing, Jinan, Jingdezhen, Jingmen, Jining, Kaifeng, Kaili, Lianyungang, Liaocheng, Linfen, Loudi, Luoyang, Mudanjiang, Nanchang, Nanyang, Neimeng, Pinggu, Puyang, Qingdao, Qiqihar, Rizhao, Sanmenxia, Shangqiu, Shangqucun, Shanyang, Shenzhen, Shihezi, Suzhou, Taian, Tangshan, Tianjin, Tongliao, Tongzhou, Ulanqab, Weifang, Weihai, Wenshan, Wuzhou, Xiamen, Xiangtan, Xiangxiang, Xiangyang, Xingan, Xingtai, Xinyang, Xuzhou, Ya'an, Yongzhou, Zhalantun, Zhangzhou, Zhoukou, Zhumadian, Zhuzhou, Zibo
Age
18 years and over
People
1,184
Run by
Capital Medical University
See details and how to joinNCT06548971
No phaseNot yet taking people in China
Effects of Different-Frequency Electroacupuncture on Suprahyoid Muscles in Post-Stroke Dysphagia: Efficacy and Neural Networks
Where
Hangzhou
Age
18 years to 80 years
People
102
Run by
Kaili Chen
See details and how to joinNCT07496762